Last month’s deal with the US government has also brought forward regulatory approval and commercialisation timelines, with ...
Zacks Investment Research on MSN
LLY trading above 50 & 200-day SMAs for 2 months: How to play the stock
Eli Lilly and Company’s LLY stock has been consistently trading above its 50-day and 200-day simple moving averages (SMAs) ...
Between the 1960s and the 1990s, during the meteoric rise in wealth and living standards of the post-World War II era, ...
Oprah Daily on MSN
A New Form of GLP-1s Could Revolutionize Weight-Loss Treatment (Again)—And It’ll Be Available in 2026
They’re definitely easier and more affordable than injectables, but do they work as well? Here’s what you need to know.
Details from two large trials of Novo Nordisk’s GLP-1 drug semaglutide showed it provided no cognitive benefit for people ...
This week, Eli Lilly secured a significant regulatory victory. The U.S. Food and Drug Administration (FDA) granted full, traditional approval for the cancer drug Jaypirca. This upgrades its status ...
The largest U.S. health insurer’s Medicare business faces investigations and policy threats. Insurers say that the rising premiums are driven by growing healthcare costs. Pledging to go after ‘waste, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback